Ixaka’s cell therapy clears early phase 3 data review
Ixaka’s cell therapy clears early phase 3 data review ntaylor [...]
Vor’s cancer cell therapy gets on FDA fast track ahead of 2022 data drop
Vor’s cancer cell therapy gets on FDA fast track ahead [...]
Researchers pinpoint autoimmune antibodies that may predict COVID-19 severity
Researchers pinpoint autoimmune antibodies that may predict COVID-19 severity klahucik [...]
Cardiff reveals early data on challenger to Amgen’s KRAS crown
Cardiff reveals early data on challenger to Amgen’s KRAS crown [...]
Obsidian bags $115M to untether cell therapy from toxic sidekick
Obsidian bags $115M to untether cell therapy from toxic sidekick [...]
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation tech
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation [...]
Sanofi’s BTK inhibitor flunks phase 3 autoimmune trial, delivering blow to $3.7B biotech bet
Sanofi’s BTK inhibitor flunks phase 3 autoimmune trial, delivering blow [...]
FDA slams the door in Humanigen’s face, rejects emergency use green light, wants more data
FDA slams the door in Humanigen’s face, rejects emergency use [...]
Science 37 teams up with Roche’s Foundation Medicine to boost home-based oncology trials
Science 37 teams up with Roche’s Foundation Medicine to boost [...]
As gene therapy safety faces scrutiny, Broad Institute proposes a safer and more efficient delivery tool
As gene therapy safety faces scrutiny, Broad Institute proposes a [...]